Long‐Term Efficacy and Safety of Mavacamten in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy: Week 78 Results From the EXPLORER‐CN Study
Background Long‐term efficacy and safety of mavacamten in Chinese patients with obstructive hypertrophic cardiomyopathy are unknown. Methods Patients who completed the 30‐week, double‐blind, placebo‐controlled treatment period in EXPLORER‐CN (A Study to Evaluate the Efficacy and Safety of Mavacamten...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2026-06-01
|
| シリーズ: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| 主題: | |
| オンライン・アクセス: | https://www.ahajournals.org/doi/10.1161/JAHA.125.046251 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
